Dr. Salman Butt, M.D

NPI: 1760664585
Total Payments
$488.12
2024 Payments
$40.97
Companies
12
Transactions
26
Medicare Patients
4,275
Medicare Billing
$1.0M

Payment Breakdown by Category

Food & Beverage$456.29 (93.5%)
Education$31.83 (6.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $456.29 24 93.5%
Education $31.83 2 6.5%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $96.37 6 $0 (2024)
Otsuka America Pharmaceutical, Inc. $84.15 6 $0 (2020)
Intuitive Surgical, Inc. $63.71 1 $0 (2018)
Horizon Therapeutics plc $57.30 3 $0 (2023)
Mallinckrodt Enterprises LLC $42.99 2 $0 (2019)
Relypsa, Inc. $38.12 2 $0 (2020)
Lilly USA, LLC $20.90 1 $0 (2024)
Aurinia Pharma U.S., Inc. $19.69 1 $0 (2021)
AstraZeneca Pharmaceuticals LP $18.55 1 $0 (2023)
Boston Scientific Corporation $17.67 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $40.97 2 Lilly USA, LLC ($20.90)
2023 $158.96 9 GlaxoSmithKline, LLC. ($60.18)
2022 $28.26 2 GlaxoSmithKline, LLC. ($16.12)
2021 $30.96 2 Aurinia Pharma U.S., Inc. ($19.69)
2020 $65.84 4 Relypsa, Inc. ($38.12)
2019 $35.83 2 Mallinckrodt Enterprises LLC ($19.49)
2018 $87.24 3 Intuitive Surgical, Inc. ($63.71)
2017 $40.06 2 Mallinckrodt LLC ($23.50)

All Payment Transactions

26 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
09/25/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $20.90 General
Category: Diabetes
01/24/2024 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $20.07 General
Category: IMMUNOLOGY
11/30/2023 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $16.53 General
Category: Phosphate binder for ESRD
10/25/2023 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $23.59 General
Category: KRYSTEXXA
10/11/2023 GlaxoSmithKline, LLC. JESDUVROQ (Drug) Food and Beverage In-kind items and services $12.85 General
Category: NEPHROLOGY
09/08/2023 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $22.44 General
Category: KRYSTEXXA
07/25/2023 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $13.29 General
Category: IMMUNOLOGY
05/10/2023 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $17.94 General
Category: IMMUNOLOGY
04/20/2023 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $18.55 General
03/16/2023 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $16.10 General
Category: IMMUNOLOGY
03/15/2023 Boston Scientific Corporation Varithena Administration Pack (Device) Food and Beverage In-kind items and services $17.67 General
Category: Varithena_PI
10/26/2022 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $16.12 General
Category: IMMUNOLOGY
05/10/2022 Vifor Pharma, Inc. Education In-kind items and services $12.14 General
10/07/2021 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Education In-kind items and services $19.69 General
Category: LUPUS NEPHRITIS
07/12/2021 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $11.27 General
Category: KRYSTEXXA
12/17/2020 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $22.22 General
Category: Hyperkalemia
06/03/2020 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $15.02 General
Category: NEPHROLOGY
03/31/2020 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $15.90 General
Category: Hyperkalemia
02/10/2020 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $12.70 General
Category: NEPHROLOGY
11/19/2019 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $16.34 General
Category: NEPHROLOGY
04/03/2019 Mallinckrodt Enterprises LLC ACTHAR (Biological) Food and Beverage In-kind items and services $19.49 General
Category: AUTOIMMUNE AND RARE DISEASE
09/07/2018 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $10.98 General
Category: NEPHROLOGY
08/09/2018 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $12.55 General
Category: NEPHROLOGY
08/02/2018 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $63.71 General
Category: SURGERY
08/31/2017 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $23.50 General
Category: AUTOIMMUNE AND RARE DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 898 2,194 $683,951 $225,421
2022 11 954 2,363 $540,812 $228,512
2021 9 1,179 2,889 $517,508 $264,522
2020 8 1,244 3,013 $584,985 $282,926
Total Patients
4,275
Total Services
10,459
Medicare Billing
$1.0M
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 205 695 $176,896 $62,828 35.5%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 28 202 $159,288 $54,098 34.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 142 440 $74,450 $26,522 35.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 223 419 $103,160 $26,220 25.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 149 195 $79,179 $25,898 32.7%
90962 Dialysis services, 1 physician visit per month (20 years or older) Office 2023 14 80 $36,802 $11,864 32.2%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 22 42 $28,148 $9,301 33.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 38 38 $12,416 $4,732 38.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 77 83 $13,611 $3,960 29.1%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 249 741 $126,748 $57,823 45.6%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 35 204 $135,251 $55,449 41.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 251 475 $83,321 $32,011 38.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 134 585 $80,006 $31,783 39.7%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 156 188 $56,550 $28,260 50.0%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 22 46 $26,360 $10,637 40.4%
90962 Dialysis services, 1 physician visit per month (20 years or older) Office 2022 11 22 $10,481 $3,517 33.6%
99291 Critical care, first 30-74 minutes Facility 2022 18 20 $8,000 $3,338 41.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 21 21 $5,623 $2,668 47.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 44 47 $6,240 $1,983 31.8%
99218 Initial hospital observation care per day, typically 30 minutes Facility 2022 13 14 $2,233 $1,043 46.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 239 804 $120,588 $64,544 53.5%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 36 217 $119,350 $59,617 50.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 240 915 $109,800 $50,986 46.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 191 230 $55,200 $35,768 64.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 154 254 $33,020 $18,791 56.9%

About Dr. Salman Butt, M.D

Dr. Salman Butt, M.D is a Nephrology healthcare provider based in Mckinney, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760664585.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Salman Butt, M.D has received a total of $488.12 in payments from pharmaceutical and medical device companies, with $40.97 received in 2024. These payments were reported across 26 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($456.29).

As a Medicare-enrolled provider, Butt has provided services to 4,275 Medicare beneficiaries, totaling 10,459 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Mckinney, TX
  • Active Since 12/04/2007
  • Last Updated 07/20/2011
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1760664585

Products in Payments

  • BENLYSTA (Biological) $83.52
  • JYNARQUE (Drug) $67.59
  • Da Vinci Surgical System (Device) $63.71
  • KRYSTEXXA (Biological) $57.30
  • ACTHAR (Biological) $42.99
  • Veltassa (Drug) $38.12
  • JARDIANCE (Drug) $20.90
  • LUPKYNIS (Drug) $19.69
  • Varithena Administration Pack (Device) $17.67
  • SAMSCA (Drug) $16.56
  • Velphoro (Drug) $16.53
  • JESDUVROQ (Drug) $12.85

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Mckinney